Finding Balance through Innovation

Kevin Lobo was named President and Chief Executive Officer for Stryker Corporation in October 2012. He was named to the Company's Board of Directors. Mr. Lobo joined Stryker in April 2011, and was most recently Group President of Stryker Orthopaedics. Orthopaedics includes the Company's Reconstructive, Osteosynthesis, Joint Preservation, Orthobiologics and Performance Solutions businesses.

Mr. Lobo has a broad and diverse 25-year business career that includes executive positions in general management and finance. After holding finance positions with KPMG and Unilever Canada, he joined Kraft Canada in 1992. He subsequently held executive positions at Rhone-Poulenc, including roles based in Europe as Worldwide Corporate Controller of the chemical spin-out, Rhodia, and General Manager of Specialty Phosphates EMEA. In 2003, he joined Johnson & Johnson at McNeil Consumer Healthcare as Chief Financial Officer. In 2004, he took on additional responsibilities as Chief Financial Officer of Ortho Women's Health and Urology and General Manager of McNeil Canada. In 2005, he was named President of Johnson & Johnson's Medical Products Canada and in 2006 he became President of Ethicon Endo-Surgery, Inc., a $4 billion business. During his time at Ethicon Endo-Surgery, Kevin led the business to develop a stronger customer focus, above-market sales growth, and top-ranking employee engagement scores.